By Elric Langton | 31st January 2022
SkinBioTherapeutics Plc (SBTX) shareholders have had a torrid time since the sale of ยฃ2 million of shares once held by OptiBiotix Health (OPTI). The shares have fallen from the second 75p peak to test the old resistance of 30p.
I am not going to harp on about past events other than to say this is typical of the short-term nature of retail investors. Some of us are incapable of investing; there is a need to trade. This is not a criticism of trading; indeed, I am on record saying we need traders for liquidity. I know I have a trigger happy finger, too, hence why I have not banked significant profits on the way down. I know I would have been itching to put the proceeds elsewhere, and thereโs no guarantee I would have made the right move. In hindsight, I know I could have doubled the number of shares had I resisted using the proceeds; thatโs the only regret.